Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PJP vs. XPH: which is better?

Bottom line

PJP vs XPH: the short answer

PJP (Invesco Pharmaceuticals ETF) and XPH (State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF) are quite different portfolios: only about 18% of their top holdings (by weight) are shared.

But XPH is far broader, holding 67 positions to 33 for PJP, so beyond the top names it adds exposure PJP doesn't have.

XPH is cheaper at 0.35% vs 0.58% — a difference of $23 a year per $10,000 invested.

Over five years, PJP returned +9.0% a year vs +2.8% for XPH.

Updated Nov 19, 2026

PJP vs XPH side by side

PJPXPH
TypeETFETF
Fund familyInvescoSPDR (State Street)
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.58%0.35%
Annual cost per $10k$58$35
10-yr cost on $10k (prospectus)$726$443
Max front loadNoneNone
12b-1 fee—0%
1-yr return+27.9%+31.6%
5-yr return (annualized)+9.0%+2.8%
10-yr return (annualized)+5.1%+1.9%
Best quarter+18.1%+28.6%
Worst quarter−14.8%−24.3%
Net assets (fund)$472.1M$428.4M
Number of holdings3367
Portfolio turnover36%69%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearPJPXPHDifference
2025+27.9%+31.6%−3.7%
2024+9.7%+5.1%+4.6%
2023−2.2%+2.9%−5.1%
2022−2.0%−9.8%+7.7%
2021+14.5%−10.5%+25.0%
2020+11.2%+14.4%−3.2%
2019+4.7%+25.7%−21.0%
2018−1.7%−15.2%+13.5%
2017+15.3%+12.0%+3.3%
2016−19.3%−23.2%+4.0%

Source: Fund prospectus bar charts

Holdings overlap

6 of PJP's top 25 holdings also appear in XPH's top 25.

Shared top holdings
HoldingPJPXPH
Merck & Co., Inc.5.06%1.65%
Corcept Therapeutics Inc.4.96%1.70%
Amneal Pharmaceuticals, Inc.3.75%1.72%
Liquidia Corp.3.66%1.86%
Ligand Pharmaceuticals Inc.3.20%1.94%
Ocular Therapeutix, Inc.2.58%1.71%

Source: SEC Form N-PORT

PJP top 10

  1. Invesco Private Prime Fund — 7.93%
  2. Abbott Laboratories — 5.67%
  3. AbbVie Inc. — 5.48%
  4. Amgen Inc. — 5.33%
  5. Johnson & Johnson — 5.18%
  6. Merck & Co., Inc. — 5.06%
  7. Eli Lilly and Co. — 5.02%
  8. Corcept Therapeutics Inc. — 4.96%
  9. Gilead Sciences, Inc. — 4.53%
  10. Pfizer Inc. — 4.50%

XPH top 10

  1. State Street Global Advisors — 8.58%
  2. Definium Therapeutics Inc — 3.09%
  3. MBX Biosciences Inc — 2.72%
  4. Alumis Inc — 2.14%
  5. AtaiBeckley Inc — 2.13%
  6. Trevi Therapeutics Inc — 2.12%
  7. Enliven Therapeutics Inc — 2.09%
  8. Amylyx Pharmaceuticals Inc — 2.04%
  9. VeraDermics Inc — 2.02%
  10. Ligand Pharmaceuticals Inc — 1.94%

FAQ

What is the difference between PJP and XPH?
PJP (Invesco Pharmaceuticals ETF) and XPH (State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF) are quite different portfolios: only about 18% of their top holdings (by weight) are shared. But XPH is far broader, holding 67 positions to 33 for PJP, so beyond the top names it adds exposure PJP doesn't have.
Which is cheaper, PJP or XPH?
XPH has the lower expense ratio (0.35%).
Should I own both PJP and XPH?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.